Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 4109-4114, September 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davies, C. d. L.
Right arrow Articles by Lindmo, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davies, C. d. L.
Right arrow Articles by Lindmo, T.

Hyperthermia-induced Changes in Antigen Expression on Human FME Melanoma Cells1

C. de L. Davies2, E. K. Rofstad and T. Lindmo

Department of Biophysics, Norsk Hydro's Institute for Cancer Research, and The Norwegian Cancer Society, Montebello, 0310 Oslo 3, Norway

Quantitative changes in the expression of three melanoma-associated antigens on human FME cells were studied by means of flow cytometry as a function of time after exposure to hyperthermia (42°C for 1, 2, and 3 h; 43.5°C for 1 and 2 h; 45°C for 20 min). The expression of the three different surface antigens p250, p210, and p97a recognized by the monoclonal antibodies 9.2.27, 5.1, and 4.1, respectively, underwent qualitatively similar changes after hyperthermia. The antigen expression was reduced immediately after end of the treatment and decreased further to reach a minimum 1 day after treatment. Then the antigen expression gradually increased and reached a maximum above the level for unheated cells before it returned to this level about 1 wk after hyperthermia. The magnitude of these effects increased with increasing temperature and with increasing heating time at a given temperature. Quantitatively there were individual variations for the three different antigens. A positive correlation was found between the surviving fraction of the cells and the minimum level of antigen expression, indicating that different heat treatments which inactivated the same number of cells induced the same reduction in antigen expression. The demonstrated therapy-induced changes in antigen expression may be of importance for the use of monoclonal antibodies in diagnostic imaging of tumor tissue after hyperthermia or as therapeutic agents in combination treatments involving hyperthermia.

1 This project has been funded in part by The Norwegian Cancer Society.

2 To whom requests for reprints should be addressed.

Received 3/ 5/85. Revised 5/28/85. Accepted 6/ 3/85.




This article has been cited by other articles:


Home page
Int ImmunolHome page
V. Milani, B. Frankenberger, O. Heinz, A. Brandl, S. Ruhland, R. D. Issels, and E. Noessner
Melanoma-associated antigen tyrosinase but not Melan-A/MART-1 expression and presentation dissociate during the heat shock response
Int. Immunol., March 1, 2005; 17(3): 257 - 268.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.